Different doses of sufentanil combined with ropivacaine on intermuscular brachial plexus block in children: a randomized controlled trial

To evaluate the efficacy of different doses of sufentanil combined with ropivacaine on brachial plexus block in pediatric regional anesthesia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032071

Enrollment

Unknown

Registered

2020-04-19

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nerve block

Interventions

RS1 group:sufentanil 0.10ug/kg

RS2 group:sufentanil 0.15ug/kg

RS3 group:sufentanil 0.20ug/kg

R group:Nil

Eligibility

Sex/Gender

All

Age

5 Years to 10 Years

Inclusion criteria

Inclusion criteria: (1) Scheduled for upper limb surgery under inhalation general anesthesia; (2) ASA I or II; (3) Aged 5-10 years old.

Exclusion criteria

Exclusion criteria: (1) Allergy to the study drugs; (2) Coagulation disorders; (3) Neuromuscular disease; (4) Severe respiratory infection.

Design outcomes

Primary

Measure	Time frame
the duration of sensory block;	—

Countries

China

Contacts

Public ContactNan Yang

Yuying Children's Hospital, the Second Affiliated Hospital of Wenzhou Medical University

nay0000@163.com+86 13957743658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026